CHMP2A 抗体 (AA 1-222)
Quick Overview for CHMP2A 抗体 (AA 1-222) (ABIN7147519)
抗原
See all CHMP2A 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 1-222
-
交叉反应
- 人
-
纯化方法
- >95%, Protein G purified
-
免疫原
- Recombinant Human Charged multivesicular body protein 2a protein (1-222AA)
-
亚型
- IgG
-
-
anti-Charged Multivesicular Body Protein 2A (CHMP2A) (Internal Region) antibody
CHMP2A 适用: 人, 大鼠, 小鼠 WB, IHC, ICC, IF 宿主: 兔 Polyclonal unconjugated
anti-Charged Multivesicular Body Protein 2A (CHMP2A) (AA 1-100) antibodyCHMP2A 适用: 大鼠 WB, ELISA, IF (cc), IF (p), IHC (p), ICC, IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Charged Multivesicular Body Protein 2A (CHMP2A) (AA 1-222) antibodyCHMP2A 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Charged Multivesicular Body Protein 2A (CHMP2A) antibody (FITC)CHMP2A 适用: 人 WB, ELISA, IHC, IHC (p) 宿主: 兔 Polyclonal FITC
anti-Charged Multivesicular Body Protein 2A (CHMP2A) antibody (HRP)CHMP2A 适用: 人 WB, ELISA, IHC, IHC (p) 宿主: 兔 Polyclonal HRP
anti-Charged Multivesicular Body Protein 2A (CHMP2A) antibody (Biotin)CHMP2A 适用: 人 WB, ELISA, IHC, IHC (p) 宿主: 兔 Polyclonal Biotin
anti-Charged Multivesicular Body Protein 2A (CHMP2A) (C-Term) antibodyCHMP2A 适用: 人, 大鼠, 小鼠, Cow, 豚鼠, 兔, Bat, 猴 WB 宿主: 兔 Polyclonal unconjugated
anti-Charged Multivesicular Body Protein 2A (CHMP2A) (N-Term) antibodyCHMP2A 适用: 人, 大鼠, 小鼠, Cow, 豚鼠, 兔, 犬, 斑马鱼, Bat, 猴, 小鸡, 非洲爪蟾 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C,-80 °C
-
储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CHMP2A (Charged Multivesicular Body Protein 2A (CHMP2A))
-
别名
- CHMP2A
-
背景
-
Background: Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis (PubMed:21310966). Together with SPAST, the ESCRT-III complex promotes nuclear envelope sealing and mitotic spindle disassembly during late anaphase (PubMed:26040712). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4.
Aliases: BC 2 antibody, BC2 antibody, Charged multivesicular body protein 2a antibody, CHM2A_HUMAN antibody, CHMP2 antibody, CHMP2a antibody, Chromatin modifying protein 2a antibody, Chromatin-modifying protein 2a antibody, hVps2 1 antibody, hVps2-1 antibody, putative breast adenocarcinoma marker antibody, Putative breast adenocarcinoma marker BC-2 antibody, Putative breast adenocarcinoma marker BC2 antibody, Vacuolar protein sorting associated protein 2 1 antibody, Vacuolar protein sorting-associated protein 2-1 antibody, Vps2 1 antibody, VPS2 antibody, Vps2-1 antibody, VPS2A antibody
-
UniProt
- O43633
-
途径
- SARS-CoV-2 Protein Interactome
抗原
-
